The Department of Defense could undermine FDA, giving the green light for experimental products
A defense bill making its way through the Senate would give the Pentagon power to approve new drugs and medical devices in some emergency instances, with clearance to ignore advice from the FDA.
The proposed policy would give the Defense Department unprecedented leeway, thanks to the bill’s vague language. The concept is alarming congressional staff and Health and Human Services officials, according to Politco, who first reported the news.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.